Secreted protein called 36P6D5 characteristic of tumors

US7897740B2 · kind B2 · utility

Assignee

• Latency, LLC · US

Inventors

• Arthur B. Raitano · Los Angeles, US
• Aya Jakobovits · Beverly Hills, US
• Mary Faris · Los Angeles, US
• Daniel Afar · Santa Monica, US
• Rene S. Hubert · Los Angeles, US
• Steve Chappell Mitchell · Santa Monica, US

Key dates

• Filing date: Feb 26, 2009
• Grant date: Mar 1, 2011
• Expiry date: Feb 26, 2029

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y02A50/30
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Described is a gene and its encoded secreted tumor antigen, termed 36P6D5, and to diagnostic and therapeutic methods and compositions useful in the management of various cancers which express 36P6D5, particularly including cancers of the bladder, kidney, prostate, breast, colon, ovary, and pancreas.